- Home
- JYNT vs TVGN Comparison
JYNT vs TVGN Comparison
Compare JYNT & TVGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- JYNT
- TVGN
- Stock Information
- Founded
- JYNT 2010
- TVGN 2020
- Country
- JYNT United States
- TVGN United States
- Employees
- JYNT N/A
- TVGN N/A
- Industry
- JYNT Multi-Sector Companies
- TVGN Blank Checks
- Sector
- JYNT Miscellaneous
- TVGN Finance
- Exchange
- JYNT Nasdaq
- TVGN Nasdaq
- Market Cap
- JYNT 149.5M
- TVGN 179.0M
- IPO Year
- JYNT 2014
- TVGN N/A
- Fundamental
- Price
- JYNT $7.80
- TVGN $0.50
- Analyst Decision
- JYNT Strong Buy
- TVGN Strong Buy
- Analyst Count
- JYNT 3
- TVGN 1
- Target Price
- JYNT $16.33
- TVGN $10.00
- AVG Volume (30 Days)
- JYNT 79.8K
- TVGN 591.7K
- Earning Date
- JYNT 11-06-2025
- TVGN 11-19-2025
- Dividend Yield
- JYNT N/A
- TVGN N/A
- EPS Growth
- JYNT N/A
- TVGN N/A
- EPS
- JYNT N/A
- TVGN N/A
- Revenue
- JYNT $54,176,002.00
- TVGN N/A
- Revenue This Year
- JYNT $7.70
- TVGN N/A
- Revenue Next Year
- JYNT $10.24
- TVGN N/A
- P/E Ratio
- JYNT N/A
- TVGN N/A
- Revenue Growth
- JYNT 263.87
- TVGN N/A
- 52 Week Low
- JYNT $7.50
- TVGN $0.46
- 52 Week High
- JYNT $13.47
- TVGN $1.92
- Technical
- Relative Strength Index (RSI)
- JYNT 33.30
- TVGN 30.75
- Support Level
- JYNT $7.69
- TVGN $0.46
- Resistance Level
- JYNT $8.62
- TVGN $0.65
- Average True Range (ATR)
- JYNT 0.31
- TVGN 0.05
- MACD
- JYNT 0.03
- TVGN -0.01
- Stochastic Oscillator
- JYNT 18.33
- TVGN 15.40
About JYNT The Joint Corp.
The Joint Corp develops, owns, operates, supports, and manages chiropractic clinics through direct ownership, management arrangements, franchising, and the sales of regional developer rights throughout the United States. The doctors of chiropractic develop personalized treatment plans to relieve patients' pain and deliver ongoing preventative care. The Company has one operating business segment; The Franchise Operations segment which is comprised of the operating activities of the franchise business unit. The Franchise Operations segment derives revenue from customers by providing access to the Company's franchise license, which represents symbolic intellectual property.
About TVGN Tevogen Bio Holdings Inc. Common Stock
Tevogen Bio Holdings Inc a clinical-stage specialty immunotherapy company harnessing CD8+ cytotoxic T lymphocytes (CD8+ CTLs or CTLs), to develop off-the-shelf, precision T cell therapies for the treatment of infectious diseases, cancers, and neurological disorders.